Last updated on April 2017

Heart Failure in Adults


Brief description of study

Heart Failure in Adults

Detailed Study Description

PHASE 2A, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE, 2-PART STUDY TO ASSESS THE SAFETY, TOLERABILITY AND PHARMACOKINETIC RESPONSE AND EXPLORE THE PHARMACODYNAMIC RESPONSE FOLLOWING 4 WEEKS OF ONCE WEEKLY SUBCUTANEOUS INJECTIONS OF PB1046 IN ADULT SUBJECTS WITH STABLE HEART FAILUREWITH REDUCED EJECTION FRACTION (HFREF) (PART 1) AND IN SUBJECTS WITH CARDIAC DYSFUNCTION SECONDARY TO DUCHENNE MUSCULAR DYSTROPHY (PART 2)

Clinical Study Identifier: TX149045

Contact Investigators or Research Sites near you

Start Over

Customer Service

Phoenix Medical Research
Peoria, AZ USA
  Connect »